COVID 19 Vaccine Update with Professor Michael Mina, MD: Safety, Efficacy, Distribution, Trials

preview_player
Показать описание
Harvard professor and epidemiologist Michael Mina MD, Ph.D. is back to give a COVID 19 Vaccine Update including:
00:00 Attention to vaccine safety in phase one, two, and three trials
00:21 Mild side effects from vaccines observed in phase 1 and 2 trials
00:32 Awareness of "fringe effects" when the vaccine is introduced to thousands or millions
00:59 Post-market surveillance of adverse effects vs. coincidence and confounding
01:31 Ensuring efficacy - new territory with a coronavirus vaccine
01:50 Sterilizing immunity
02:06 Relatively weak immune response from coronaviruses vs severity
02:29 Polio and measles vaccines create robust immunity
02:59 New technology being used in some SARS-CoV-2 vaccines
03:47 Cautious optimism about the efficacy of vaccines
04:02 Herd immunity
04:43 Who is going to get the COVID-19 vaccine first? Which countries?
05:15 Medical professionals likely the first to receive vaccines
06:02 Will COVID 19 vaccines block transmission and spread?
06:10 Should kids get the vaccine?
06:37 How well will vaccines work in the elderly and immunocompromised?
07:46 How quickly can the COVID vaccines get distributed? By the end of this year?

MedCram has no financial disclosures related to any medical products or vaccines, and from our understanding, Dr. Mina does not either.

THE MEDCRAM WEBSITE:

MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:

Get notified of new videos by hitting the bell icon:

OTHER MEDCRAM VIDEOS FEATURING DR. MICHAEL MINA:

FOLLOW US ON SOCIAL MEDIA:

DISCLAIMER:

MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

------------------------------------------------------

#COVID19 #SARSCOV2 #Science
Рекомендации по теме
Комментарии
Автор

A rushed-to-market vaccine with the manufacturer(s) absolved of any liability? I'll gladly let some one else have my dose. I'm happy to wait many years for it. I do appreciate Dr. Mina's explanation, though.

jimmyco
Автор

Being a type I diabetic for 42 years and in relatively good health, there is no way I would trust any vaccine before the first two years of public rollout. I have my precautions and immune building regime in place for the time being. MedCram has certainly been the voice of clarity through all this. Cannot say enough about the integrity here.

wearemilesfromnowhere
Автор

Since when has big pharma been concerned about safety ? Profit are greater then the fines.

todd
Автор

I have lived 30 years with multiple auto-immunity, more than one, I just feel that after seeing many specialists, that the immune system is very complicated & not fully understood. I would not take a vaccine unless you can prove that it's ok that someone with MAS can tolerate a vaccine for CoVid.

MsSunstoned
Автор

I don’t know if the trial periods for this vaccine is enough to rule out the adverse events.

nancyrahif
Автор

Tell us more about nutrition information and how building a strong immune system works.

SLIT for allergies are very effective

MyJohnnyboy
Автор

I just read that COVID-19 vaccines are unlikely to be effective for obese and other high risk persons because these conditions cause inflammation which causes the immune system to be ineffective. So, the vaccine is unlikely to be effective to those who might need it most. The article said that the same is true for flu vaccines - ineffective many unhealthy people

timothykeith
Автор

Is it wise to put all our medical heroes at risk at the same time?Especially if it is decided to skip to the end earlier?

cheryltison
Автор

No thank you..Way to rushed for safety. Very dangerous,

josephdavis
Автор

In big store They sell everything from cars, guns, medicine, food...but on the door is writing: "We or producers 
do not are responsible for quality, safety or efficacy of these products...Q?, Will You buy or no any of these products.

gorgig
Автор

I'm trying to figure out how efficacious vaccines will be without widespread testing ...

k.c
Автор

Surprised to see them discussing this topic since Youtube and big tech like to censor controversial topics

polaris
Автор

Humans are Guinea pigs in this. That is what I am hearing. There has to be a better way to deal with this. Someone can have my dose. I would rather address via improved immunity, better diet, preventing metabolic diseases like diabetes. We are rushing something that sounds like could blow up and make things worse and just not work at all. Why not also invest more in educating people better on how to prevent beyond just wearing a mask (diet and supplements) and taking better care of elderly. Invest in educating and not just inducing fear and dependency on a vaccine fix. They only tool that is really being hyped is a rushed vaccine, when their are other tools in the tool box.

expressoyourself
Автор

Without challenge tests, how do we know if it works

AC-cgsp
Автор

From what I can tell, we don't have a working vaccine yet, so there's no point talking about how to distribute it.

KevinSolway
Автор

Vaccine development and distribution explained Very Clearly. Thanks so much MedCram and Dr Mina.

blackiecortez
Автор

Why are death rates so low while cases have been increasing for over a month. Hospitalisations and deaths are not happening?

nn-ujiv
Автор

The vaccine sounds so exciting, can't wait not to take it.

jasintosamora
Автор

Cautious optimism presented very well.

BillyLapTop
Автор

What will the criteria be for choosing which vaccine(s) will be used initially?

dfortmd